A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
NCT01039428
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperphosphatemia
Chronic Kidney Disease
Interventions
DIETARY_SUPPLEMENT:
HS219
DIETARY_SUPPLEMENT:
Placebo
Sponsor
KDL Inc.